Brain metastases from esophageal cancer
暂无分享,去创建一个
[1] D. Schadendorf,et al. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial. , 2018, The Lancet. Oncology.
[2] S. Marnitz,et al. Postoperative local fractionated radiotherapy for resected single brain metastases , 2018, Strahlentherapie und Onkologie.
[3] San-Gang Wu,et al. Patterns of Distant Metastasis Between Histological Types in Esophageal Cancer , 2018, Front. Oncol..
[4] J. Szustakowski,et al. Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden , 2018, The New England journal of medicine.
[5] Qiaoqiao Li,et al. Characteristics and Treatment of Brain Metastases from Esophageal Squamous Cell Carcinoma , 2018, Journal of Cancer.
[6] L. Collette,et al. Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with one to three brain metastases and favorable prognoses: a secondary analysis of EORTC 22952-26001 , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] Alexander Radbruch,et al. Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO) , 2017, Neuro-oncology.
[8] A. Vortmeyer,et al. Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial. , 2016, The Lancet. Oncology.
[9] A. Mehrabi,et al. Brain metastasis from gastrointestinal cancers: a systematic review , 2014, International journal of clinical practice.
[10] Satoshi Suzuki,et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. , 2014, The Lancet. Oncology.
[11] M. Proescholdt,et al. Surgical Resection of Brain Metastases—Impact on Neurological Outcome , 2013, International journal of molecular sciences.
[12] L. Collette,et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] S. Yoshida. Brain metastasis in patients with esophageal carcinoma. , 2007, Surgical neurology.
[14] Raymond Sawaya,et al. Metastasis of esophageal carcinoma to the brain , 2003, Cancer.
[15] K. Ogawa,et al. Brain metastases from esophageal carcinoma , 2002, Cancer.
[16] L Gaspar,et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. , 1997, International journal of radiation oncology, biology, physics.
[17] Keunchil Park,et al. Long-term survival in patients with advanced non-small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study. , 2019, European journal of cancer.
[18] L. Collette,et al. A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] J. Luketich,et al. Oesophageal carcinoma , 2013, The Lancet.